NYSE - Delayed Quote USD

Select Medical Holdings Corporation (SEM)

34.55 +0.64 (+1.89%)
At close: May 31 at 4:00 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
6,787,887.00
6,664,058.00
6,333,538.00
6,204,515.00
5,531,713.00
--
Cost of Revenue
5,807,808.00
5,732,017.00
5,600,161.00
5,285,149.00
4,710,372.00
--
Gross Profit
980,079.00
932,041.00
733,377.00
919,366.00
821,341.00
--
Operating Expense
382,695.00
377,167.00
330,094.00
205,592.00
253,684.00
--
Operating Income
597,384.00
554,874.00
403,283.00
713,774.00
567,657.00
--
Net Non Operating Interest Income Expense
-200,831.00
-198,639.00
-169,111.00
-130,635.00
-153,011.00
--
Other Income Expense
27,986.00
26,121.00
26,407.00
46,583.00
41,827.00
--
Pretax Income
424,539.00
382,356.00
260,579.00
629,722.00
456,473.00
--
Tax Provision
92,898.00
82,625.00
62,553.00
129,773.00
111,867.00
--
Net Income Common Stockholders
259,985.00
234,718.00
153,385.00
388,790.00
250,099.00
--
Average Dilution Earnings
--
--
--
--
--
1.00
Diluted NI Available to Com Stockholders
259,985.00
234,718.00
153,385.00
388,790.00
250,099.00
--
Basic EPS
2.10
1.91
1.23
2.98
1.93
--
Diluted EPS
2.10
1.91
1.23
2.98
1.93
--
Basic Average Shares
123,431.50
123,105.00
122,511.00
130,249.00
129,780.00
--
Diluted Average Shares
123,431.50
123,105.00
122,511.00
130,249.00
129,780.00
--
Total Operating Income as Reported
597,384.00
554,874.00
403,283.00
713,774.00
567,657.00
--
Total Expenses
6,190,503.00
6,109,184.00
5,930,255.00
5,490,741.00
4,964,056.00
--
Net Income from Continuing & Discontinued Operation
269,583.00
243,491.00
158,994.00
402,225.00
258,995.00
--
Normalized Income
281,060.08
255,009.53
158,994.00
400,513.93
249,642.82
--
Interest Income
--
--
--
5,350.00
--
--
Interest Expense
200,831.00
198,639.00
169,111.00
135,985.00
153,011.00
--
Net Interest Income
-200,831.00
-198,639.00
-169,111.00
-130,635.00
-153,011.00
--
EBIT
625,370.00
580,995.00
429,690.00
765,707.00
609,484.00
--
EBITDA
835,756.00
789,737.00
635,515.00
968,352.00
815,143.00
--
Reconciled Cost of Revenue
5,807,808.00
5,732,017.00
5,600,161.00
5,285,149.00
4,710,372.00
--
Reconciled Depreciation
210,386.00
208,742.00
205,825.00
202,645.00
205,659.00
--
Net Income from Continuing Operation Net Minority Interest
269,583.00
243,491.00
158,994.00
402,225.00
258,995.00
--
Total Unusual Items Excluding Goodwill
-14,692.00
-14,692.00
--
2,155.00
12,387.00
--
Total Unusual Items
-14,692.00
-14,692.00
--
2,155.00
12,387.00
--
Normalized EBITDA
850,448.00
804,429.00
635,515.00
966,197.00
802,756.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-3,214.92
-3,173.47
--
443.93
3,034.82
--
12/31/2019 - 9/25/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers